[Diabetic nephropathy].
Sasaki
Motofumi
M
Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
Shikata
Kenichi
K
Makino
Hirofumi
H
D000959:Antihypertensive Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D003937:Diagnosis, Differential; D004032:Diet; D005919:Glomerular Filtration Rate; D017127:Glycation End Products, Advanced; D006801:Humans; D007004:Hypoglycemic Agents; D007678:Kidney Glomerulus / Q000098:blood supply / Q000503:physiopathology; D018384:Oxidative Stress; D011108:Polymers / Q000378:metabolism; D011379:Prognosis; D011493:Protein Kinase C / Q000378:metabolism
D000959:Antihypertensive Agents; D017127:Glycation End Products, Advanced; D007004:Hypoglycemic Agents; D011108:Polymers; C024617:polyol; D011493:Protein Kinase C